The DOI matches its Crossref record; 112 of the 112 references it cites were found in a registry or an index.
Bone loss in inflammatory disorders
Open accessAbstract
Chronic inflammatory diseases of almost any cause are associated with bone loss. Bone loss is due to direct effects of inflammation, poor nutrition, reduced lean body mass, immobility and the effects of treatments, especially glucocorticoids. These mechanisms are complex and interrelated but are ultimately mediated through effects on the bone remodelling cycle. Inflammatory disease can increase bone resorption, decrease bone formation but most commonly impacts on both of these processes resulting in an uncoupling of bone formation from resorption in favour of excess resorption. This review will illustrate these interactions between inflammation and bone metabolism and discuss how these are, and might be, manipulated as therapies for inflammation related bone loss.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biochemical and Biophysical Research Communications
(1960) · Nature · doi:10.1038/186124d0 · Cited by 6,700
Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.
Simonet, W. S., Lacey, D. L., Dunstan, C. R., Kelley, M., Chang, M.-S., Lüthy, R., Nguyen, H. Q., Wooden, S., Bennett, L., Boone, T., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80209-3 · Cited by 5,130
Toll-Like Receptor Triggering of a Vitamin D-Mediated Human Antimicrobial Response
Liu, P. T., Stenger, S., Li, H., Wenzel, L., Tan, B. H., Krutzik, S. R., Ochoa, M. T., Schauber, J., Wu, K., Meinken, C., et al. (2006) · Science · doi:10.1126/science.1123933 · Cited by 3,924 · cited 1×
“This ability can influence the function of antigen-presenting cells and the capacity of macrophages to kill intracellular pathogens e.g. mycobacteria (Hewison et al. 2003, Liu et al. 2006).”
BackgroundJOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
HOSKINS, R. G. (1953) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-13-4-473 · Cited by 3,780
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph node organogenesis.
Kong, Y.-Y., Yoshida, H., Sarosi, I., Tan, H.-L., Timms, E., Capparelli, C., Morony, S., Oliveira-dos-Santos, A. J., Van, G., Itie, A., et al. (1999) · Nature · doi:10.1038/16852 · Cited by 3,351 · cited 3×
“The importance of OPG and RANKL are highlighted in various mouse models, including mice lacking RANK or RANKL, or overexpressing OPG (Simonet et al. 1997, Dougall et al. 1999, Kong et al. 1999b).”
BackgroundLDL Receptor-Related Protein 5 (LRP5) Affects Bone Accrual and Eye Development
Gong, Y., Slee, R. B., Fukai, N., Rawadi, G., Roman-Roman, S., Reginato, A. M., Wang, H., Cundy, T., Glorieux, F. H., Lev, D., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00571-2 · Cited by 2,235
MECHANISMS OF WNT SIGNALING IN DEVELOPMENT
Wodarz, A., & Nusse, R. (1998) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.14.1.59 · Cited by 2,017
Molecular and cellular endocrinology
(1995) · Journal of Endocrinology · doi:10.1677/joe.0.147so19 · Cited by 1,991
Carter, H. E., Bhattacharyya, P. K., Weidman, K. R., & Fraenkel, G. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.1981.tb06727.x · Cited by 1,896
Kong, Y.-Y., Feige, U., Sarosi, I., Bolon, B., Tafuri, A., Morony, S., Capparelli, C., Li, J., Elliott, R., McCabe, S., et al. (1999) · Nature · doi:10.1038/46303 · Cited by 1,856
Weinstein, R. S., Jilka, R. L., Parfitt, A. M., & Manolagas, S. C. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2799 · Cited by 1,753
Manolagas, S. C., & Jilka, R. L. (1995) · New England Journal of Medicine · doi:10.1056/nejm199502023320506 · Cited by 1,668
Sato, K., Suematsu, A., Okamoto, K., Yamaguchi, A., Morishita, Y., Kadono, Y., Tanaka, S., Kodama, T., Akira, S., Iwakura, Y., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061775 · Cited by 1,554
Tian, E., Zhan, F., Walker, R., Rasmussen, E., Ma, Y., Barlogie, B., & Shaughnessy, J. D. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030847 · Cited by 1,503
RANK is essential for osteoclast and lymph node development.
Dougall, W. C., Glaccum, M., Charrier, K., Rohrbach, K., Brasel, K., De Smedt, T., Daro, E., Smith, J., Tometsko, M. E., Maliszewski, C. R., et al. (1999) · Genes & Development · doi:10.1101/gad.13.18.2412 · Cited by 1,478
Russell, R. G. G., Watts, N. B., Ebetino, F. H., & Rogers, M. J. (2008) · Osteoporosis International · doi:10.1007/s00198-007-0540-8 · Cited by 1,411
Kobayashi, K., Takahashi, N., Jimi, E., Udagawa, N., Takami, M., Kotake, S., Nakagawa, N., Kinosaki, M., Yamaguchi, K., Shima, N., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.2.275 · Cited by 1,304
Dickkopf-1 is a master regulator of joint remodeling
Diarra, D., Stolina, M., Polzer, K., Zwerina, J., Ominsky, M. S., Dwyer, D., Korb, A., Smolen, J., Hoffmann, M., Scheinecker, C., et al. (2007) · Nature Medicine · doi:10.1038/nm1538 · Cited by 1,298
Little, R. D., Folz, C., Manning, S. P., Swain, P. M., Zhao, S.-C., Eustace, B., Lappe, M. M., Spitzer, L., Zweier, S., Braunschweiger, K., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/338450 · Cited by 1,282
Hofbauer, L. C., Khosla, S., Dunstan, C. R., Lacey, D. L., Boyle, W. J., & Riggs, B. L. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.1.2 · Cited by 1,173
Li, J., Sarosi, I., Yan, X.-Q., Morony, S., Capparelli, C., Tan, H.-L., McCabe, S., Elliott, R., Scully, S., Van, G., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.4.1566 · Cited by 1,119
Glucocorticoid-induced osteoporosis: pathophysiology and therapy
Canalis, E., Mazziotti, G., Giustina, A., & Bilezikian, J. P. (2007) · Osteoporosis International · doi:10.1007/s00198-007-0394-0 · Cited by 1,114
Tesmer, L. A., Lundy, S. K., Sarkar, S., & Fox, D. A. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00628.x · Cited by 1,102
Osteocytes, mechanosensing and Wnt signaling
Bonewald, L. F., & Johnson, M. L. (2008) · Bone · doi:10.1016/j.bone.2007.12.224 · Cited by 1,076 · cited 1×
“This is likely to be through modulation of the other major pathways that couple bone formation and resorption such as the wnt pathway discussed above (Bonewald & Johnson 2008).”
BackgroundIncreased bone formation by prevention of osteoblast apoptosis with parathyroid hormone
Jilka, R. L., Weinstein, R. S., Bellido, T., Roberson, P., Parfitt, A. M., & Manolagas, S. C. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6610 · Cited by 1,043
11β-Hydroxysteroid dehydrogenase type 1: a tissue specific regulator of glucocorticoid response
Tomlinson, J. W., Walker, E. A., Bujalska, I. J., Draper, N., Lavery, G. G., Cooper, M. S., Hewison, M., & Stewart, P. M. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0031 · Cited by 969 · cited 1×
“It is now clear that the levels of active glucocorticoids present within the circulation can differ from that in the tissues due to tissue metabolism of glucocorticoids by intracellular enzymes (Tomlinson et al. 2004).”
Self-citationTeriparatide or Alendronate in Glucocorticoid-Induced Osteoporosis
Saag, K. G., Shane, E., Boonen, S., Marín, F., Donley, D. W., Taylor, K. A., Dalsky, G. P., & Marcus, R. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa071408 · Cited by 914
The Effect of Glucocorticoids on Joint Destruction in Rheumatoid Arthritis
Kirwan, J. R. (1995) · New England Journal of Medicine · doi:10.1056/nejm199507203330302 · Cited by 817
Wnt signaling in osteoblasts and bone diseases
Westendorf, J. J., Kahler, R. A., & Schroeder, T. M. (2004) · Gene · doi:10.1016/j.gene.2004.06.044 · Cited by 808
Merlino, L. A., Curtis, J., Mikuls, T. R., Cerhan, J. R., Criswell, L. A., & Saag, K. G. (2004) · Arthritis & Rheumatism · doi:10.1002/art.11434 · Cited by 795
Hofbauer, L. C., Gori, F., Riggs, B. L., Lacey, D. L., Dunstan, C. R., Spelsberg, T. C., & Khosla, S. (1999) · Endocrinology · doi:10.1210/endo.140.10.7034 · Cited by 794 · cited 1×
“This effect is also thought to be via osteoblasts through a decrease in OPG and increase in RANKL expression (Hofbauer et al. 1999).”
BackgroundOsteoclast–osteoblast communication
Matsuo, K., & Irie, N. (2008) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2008.03.027 · Cited by 780
Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis
Zhao, C., Irie, N., Takada, Y., Shimoda, K., Miyamoto, T., Nishiwaki, T., Suda, T., & Matsuo, K. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.05.012 · Cited by 777
Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity
Adams, J. S., & Hewison, M. (2008) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0716 · Cited by 775
Sequential roles of Hedgehog and Wnt signaling in osteoblast development
Hu, H., Hilton, M. J., Tu, X., Yu, K., Ornitz, D. M., & Long, F. (2005) · Development · doi:10.1242/dev.01564 · Cited by 682
Generalised bone loss in patients with early rheumatoid arthritis.
GOUGH, A. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91049-9 · Cited by 630
Cohen, S. B., Dore, R. K., Lane, N. E., Ory, P. A., Peterfy, C. G., Sharp, J. T., van der Heijde, D., Zhou, L., Tsuji, W., Newmark, R., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23417 · Cited by 576
DHEA in elderly women and DHEA or testosterone in elderly men.
Nair, K. S., Rizza, R. A., O'Brien, P., Dhatariya, K., Short, K. R., Nehra, A., Vittone, J. L., Klee, G. G., Basu, A., Basu, R., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054629 · Cited by 566
Osteoimmunology: Interactions of the Bone and Immune System
Lorenzo, J., Horowitz, M., & Choi, Y. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0038 · Cited by 563
Inhibition of Osteoblast Differentiation by Tumor Necrosis Factor-α*
Gilbert, L., He, X., Farmer, P., Boden, S., Kozlowski, M., Rubin, J., & Nanes, M. S. (2000) · Endocrinology · doi:10.1210/endo.141.11.7739 · Cited by 555
Thomson, B. M., Mundy, G. R., & Chambers, T. J. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.138.3.775 · Cited by 536
Deletion of a Single Allele of the Dkk1 Gene Leads to an Increase in Bone Formation and Bone Mass
Morvan, F., Boulukos, K., Clément-Lacroix, P., Roman, S. R., Suc-Royer, I., Vayssière, B., Ammann, P., Martin, P., Pinho, S., Pognonec, P., et al. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.060311 · Cited by 524
Sims, N. A., & Gooi, J. H. (2008) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2008.07.016 · Cited by 513
Nakashima, T., Kobayashi, Y., Yamasaki, S., Kawakami, A., Eguchi, K., Sasaki, H., & Sakai, H. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3379 · Cited by 509
Bernstein, C. N., Blanchard, J. F., Leslie, W., Wajda, A., & Yu, B. N. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-10-200011210-00012 · Cited by 474
Hewison, M., Freeman, L., Hughes, S. V., Evans, K. N., Bland, R., Eliopoulos, A. G., Kilby, M. D., Moss, P. A. H., & Chakraverty, R. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.11.5382 · Cited by 449
Kotake, S., Udagawa, N., Hakoda, M., Mogi, M., Yano, K., Tsuda, E., Takahashi, K., Furuya, T., Ishiyama, S., Kim, K., et al. (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200105)44:5<1003::aid-anr179>3.0.co;2-# · Cited by 420
Convergence between bone and energy homeostases: Leptin regulation of bone mass
Karsenty, G. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.10.008 · Cited by 418
Diagnosis and management of hypocalcaemia
Cooper, M. S., & Gittoes, N. J. L. (2008) · BMJ · doi:10.1136/bmj.39582.589433.be · Cited by 415
Self-citationNew Developments in the Pathogenesis and Treatment of Steroid-Induced Osteoporosis
Manolagas, S. C., & Weinstein, R. S. (1999) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1999.14.7.1061 · Cited by 388
Osteoclast differentiation independent of the TRANCE–RANK–TRAF6 axis
Kim, N., Kadono, Y., Takami, M., Lee, J., Lee, S.-H., Okada, F., Kim, J. H., Kobayashi, T., Odgren, P. R., Nakano, H., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050978 · Cited by 370
Seminars in cell and developmental biology
Smyth, I. M., & Bertram, J. F. (2019) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2018.11.003 · Cited by 351
The Effects of Anorexia Nervosa on Bone Metabolism in Female Adolescents1
Soyka, L. A., Grinspoon, S., Levitsky, L. L., Herzog, D. B., & Klibanski, A. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.12.6207 · Cited by 327
Weinstein, R. S., Chen, J.-R., Powers, C. C., Stewart, S. A., Landes, R. D., Bellido, T., Jilka, R. L., Parfitt, A. M., & Manolagas, S. C. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214538 · Cited by 313
Armstrong, V. J., Muzylak, M., Sunters, A., Zaman, G., Saxon, L. K., Price, J. S., & Lanyon, L. E. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703224200 · Cited by 273
Froicu, M., & Cantorna, M. T. (2007) · BMC Immunology · doi:10.1186/1471-2172-8-5 · Cited by 273
Bultink, I. E. M., Lems, W. F., Kostense, P. J., Dijkmans, B. A. C., & Voskuyl, A. E. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21110 · Cited by 253
Vis, M., Havaardsholm, E. A., Haugeberg, G., Uhlig, T., Voskuyl, A. E., van de Stadt, R. J., Dijkmans, B. A. C., Woolf, A. D., Kvien, T. K., & Lems, W. F. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.044198 · Cited by 246
Rheumatoid cachexia: metabolic abnormalities, mechanisms and interventions
Rall, L. C. (2004) · Rheumatology · doi:10.1093/rheumatology/keh321 · Cited by 244
Determinants of Skeletal Loss and Recovery in Anorexia Nervosa
Miller, K. K., Lee, E. E., Lawson, E. A., Misra, M., Minihan, J., Grinspoon, S. K., Gleysteen, S., Mickley, D., Herzog, D., & Klibanski, A. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2818 · Cited by 243
Risk of vertebral fracture in women with rheumatoid arthritis.
Spector, T. D., Hall, G. M., McCloskey, E. V., & Kanis, J. A. (1993) · BMJ · doi:10.1136/bmj.306.6877.558 · Cited by 230
Parathyroid hormone — a bone anabolic and catabolic agent
POOLE, K., & REEVE, J. (2005) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2005.07.004 · Cited by 230
Cells of the synovium in rheumatoid arthritis. T lymphocytes.
Lundy, S. K., Sarkar, S., Tesmer, L. A., & Fox, D. A. (2007) · Arthritis Research & Therapy · doi:10.1186/ar2107 · Cited by 229
High-Sensitivity C-Reactive Protein and Risk of Nontraumatic Fractures in the Bruneck Study
Schett, G. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.22.2495 · Cited by 228
Cooper, M. S., Bujalska, I., Rabbitt, E., Walker, E. A., Bland, R., Sheppard, M. C., Hewison, M., & Stewart, P. M. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.6.1037 · Cited by 227
Self-citationTomlinson, J. W., Moore, J., Cooper, M. S., Bujalska, I., Shahmanesh, M., Burt, C., Strain, A., Hewison, M., & Stewart, P. M. (2001) · Endocrinology · doi:10.1210/endo.142.5.8168 · Cited by 222 · cited 1×
“This induction appears to be tissue dependent and the extent of induction can vary between sites even in the same tissue (Tomlinson et al. 2001, Hardy et al. 2006).”
BackgroundSelf-citationBellows, C. G., Heersche, J. N. M., & Aubin, J. E. (1990) · Developmental Biology · doi:10.1016/0012-1606(90)90060-v · Cited by 221
LRP5 and Wnt Signaling: A Union Made for Bone
Johnson, M. L., Harnish, K., Nusse, R., & Van Hul, W. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.040816 · Cited by 212
Leonard, M. B., Feldman, H. I., Shults, J., Zemel, B. S., Foster, B. J., & Stallings, V. A. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040367 · Cited by 206
Corticosteroid-Induced Bone Loss in Men
Pearce, G. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.3.801 · Cited by 184
Wang, F.-S., Ko, J.-Y., Yeh, D.-W., Ke, H.-C., & Wu, H.-L. (2008) · Endocrinology · doi:10.1210/en.2007-0910 · Cited by 173
Expression and functional consequences of 11β-hydroxysteroid dehydrogenase activity in human bone
Cooper, M. S., Walker, E. A., Bland, R., Fraser, W. D., Hewison, M., & Stewart, P. M. (2000) · Bone · doi:10.1016/s8756-3282(00)00344-6 · Cited by 170
Self-citationSylvester, F. A., Wyzga, N., Hyams, J. S., Davis, P. M., Lerer, T., Vance, K., Hawker, G., & Griffiths, A. M. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20006 · Cited by 169
Eating bone or adding it: the Wnt pathway decides
Goldring, S. R., & Goldring, M. B. (2007) · Nature Medicine · doi:10.1038/nm0207-133 · Cited by 161
Chiodini, I., Carnevale, V., Torlontano, M., Fusilli, S., Guglielmi, G., Pileri, M., Modoni, S., Giorgio, A. D., Liuzzi, A., Minisola, S., et al. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.6.4880 · Cited by 154
Role of oestrogen in the regulation of bone turnover at the menarche
Eastell, R. (2005) · Journal of Endocrinology · doi:10.1677/joe.1.06059 · Cited by 152
Eijken, M., Koedam, M., van Driel, M., Buurman, C. J., Pols, H. A. P., & van Leeuwen, J. P. T. M. (2006) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2005.11.034 · Cited by 147
Pers, J., Saraux, A., Pierre, R., & Youinou, P. (2008) · Journal of Periodontology · doi:10.1902/jop.2008.070616 · Cited by 143
Bone mass and mineral metabolism in liver transplant patients treated with FK506 or cyclosporine A
Monegal, A., Navasa, M., Guañabens, N., Peris, P., Pons, F., de Osaba, M. J. M., Rimola, A., Rodés, J., & Muñoz-Gómez, J. (2001) · Calcified Tissue International · doi:10.1007/bf02678145 · Cited by 142
Sato, K., Suematsu, A., Okamoto, K., Yamaguchi, A., Morishita, Y., Kadono, Y., Tanaka, S., Kodama, T., Akira, S., Iwakura, Y., et al. (2006) · The Journal of Cell Biology · doi:10.1083/jcb1754oia8 · Cited by 138
Bone mineral density in patients with recently diagnosed inflammatory bowel disease
Schoon, E. J., Blok, B. M., Geerling, B. J., Rüssel, M. G., Stockbrügger, R. W., & Brummer, R. J. (2000) · Gastroenterology · doi:10.1053/gast.2000.19280 · Cited by 137
Zehnder, D., Quinkler, M. O., Eardley, K. S., Bland, R., Lepenies, J., Hughes, S. V., Raymond, N. T., Howie, A. J., Cockwell, P., Stewart, P. M., et al. (2008) · Kidney International · doi:10.1038/ki.2008.453 · Cited by 136
High Bone Density Due to a Mutation in LDL-Receptor–Related Protein 5
Little, R. D., Recker, R. R., & Johnson, M. L. (2002) · New England Journal of Medicine · doi:10.1056/nejm200209193471216 · Cited by 133
The Effects of Anorexia Nervosa on Bone Metabolism in Female Adolescents
Soyka, L. A. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.12.4489 · Cited by 133
Lien, G., Flatø, B., Haugen, M. A., Vinje, O., Sørskaar, D., Dale, K., Johnston, V., Egeland, T., & Førre, Ø. T. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11097 · Cited by 123
Local and systemic glucocorticoid metabolism in inflammatory arthritis
Hardy, R., Rabbitt, E. H., Filer, A. D., Emery, P., Hewison, M., Stewart, P. M., Gittoes, N. J. L., Buckley, C. D., Raza, K., & Cooper, M. S. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.090662 · Cited by 121
Self-citationHardy, R., Filer, A. D., Cooper, M. S., Parsonage, G. N., Raza, K., Hardie, D. L., Rabbitt, E. H., Stewart, P. M., Buckley, C. D., & Hewison, M. (2006) · Arthritis Research & Therapy · doi:10.1186/ar1993 · Cited by 120
Self-citationMolecular mechanisms of inflammatory bone damage: emerging targets for therapy
Herman, S., Krönke, G., & Schett, G. A. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2008.04.001 · Cited by 111
Bones in coeliac disease: diagnosis and treatment
Corazza, G. R., Stefano, M. D., Mauriño, E. C., & Bai, J. C. (2005) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2005.01.002 · Cited by 101
Rabbitt, E. H., Lavery, G. G., Walker, E. A., Cooper, M. S., Stewart, P. M., & Hewison, M. (2002) · The FASEB Journal · doi:10.1096/fj.01-0582com · Cited by 100
Self-citationBeishuizen, A., THIJS, L. G., & Vermes, I. (2002) · Critical Care · doi:10.1186/cc1530 · Cited by 98
11β-Hydroxysteroid Dehydrogenase Type 1 Activity Predicts the Effects of Glucocorticoids on Bone
Cooper, M. S., Blumsohn, A., Goddard, P. E., Bartlett, W. A., Shackleton, C. H. L., Eastell, R., Hewison, M., & Stewart, P. M. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-022025 · Cited by 97
Self-citationMethotrexate in the treatment of rheumatoid arthritis. II. In vivo effects on bone mineral density
Minaur, N., Kounali, D., Vedi, S., Compston, J. E., Beresford, J. N., & Bhalla, A. K. (2002) · British journal of rheumatology · doi:10.1093/rheumatology/41.7.741 · Cited by 96
Dissociation of Serum Dehydroepiandrosterone and Dehydroepiandrosterone Sulfate in Septic Shock
Arlt, W., Hammer, F., Sanning, P., Butcher, S. K., Lord, J. M., Allolio, B., Annane, D., & Stewart, P. M. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2258 · Cited by 94
The effect of microgravity on morphology and gene expression of osteoblasts in vitro
Carmeliet, G., & Bouillon, R. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.9001.s129 · Cited by 93
The Skeletal Effects of Glucocorticoid Excess Override Those of Orchidectomy in Mice
Weinstein, R. S., Jia, D., Powers, C. C., Stewart, S. A., Jilka, R. L., PARFITT, A. M., & Manolagas, S. C. (2004) · Endocrinology · doi:10.1210/en.2003-1133 · Cited by 92
Wetzsteon, R. J., Justine Shults, A., Zemel, B. S., Gupta, P., Burnham, J. M., Herskovitz, R. M., Howard, K. M., & Leonard, M. B. (2008) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.081101 · Cited by 87
Stegk, J. P., Ebert, B., Martin, H.-J., & Maser, E. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.10.030 · Cited by 78
Wnt signaling: An embarrassment of receptors
Bejsovec, A. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00852-6 · Cited by 77
Sensitivity of bone to glucocorticoids
Cooper, M. S. (2004) · Clinical Science · doi:10.1042/cs20040070 · Cited by 72
Self-citationCorticosteroid Osteoporosis: Practical Implications of Recent Trials
Sambrook, P. N. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.9.1645 · Cited by 70
Hansen, M. S., Florescu, A., Stoltenberg, M., Pødenphant, J., Pedersen-Zbinden, B., Hørslev-petersen, K., Hyldstrup, L., & Lorenzen, I. (1996) · Scandinavian Journal of Rheumatology · doi:10.3109/03009749609065648 · Cited by 70
DHEA in Elderly Women and DHEA or Testosterone in Elderly Men
Nair, K. S., Rizza, R. A., Brien, P. O., Dhatariya, K., Short, K. R., Nehra, A. X., Vittone, J. L., Klee, G. G., Basu, A., Basu, R., et al. (2007) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000253416.67338.dc · Cited by 69
The pituitary–adrenal axis and body composition
Fernandez-Rodriguez, E., Stewart, P. M., & Cooper, M. S. (2009) · Pituitary · doi:10.1007/s11102-008-0098-2 · Cited by 49 · cited 1×
“Bone loss is a common feature in this situation implying that glucocorticoids can induce bone disease in isolation (Chiodini et al. 1998, Fernandez-Rodriguez et al. 2008).”
BackgroundSelf-citationBurnham, J. M., Justine Shults, A., Petit, M. A., Semeao, E. J., Beck, T., Zemel, B. S., & Leonard, M. B. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.070110 · Cited by 49
Anabolic Therapy in Glucocorticoid-Induced Osteoporosis
Sambrook, P. N. (2007) · New England Journal of Medicine · doi:10.1056/nejme0706770 · Cited by 39
Bryndová, J., Žbánková, Š., Kment, M., & Pácha, J. (2004) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520410004659 · Cited by 27
Weinstein, R. S., Chen, J., Powers, C. C., Stewart, S. A., Landes, R. D., Bellido, T., Jilka, R. L., PARFITT, A. M., & Manolagas, S. C. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200214538 · Cited by 25
Rapid hip bone loss in active Crohn's disease patients receiving short‐term corticosteroid therapy
Tobias, J. H., Sasi, M. R., Greenwood, R., & Probert, C. S. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.02207.x · Cited by 22
11β-Hydroxysteroid Dehydrogenase, an Amplifier of Glucocorticoid Action in Osteoblasts
CANALIS, E. M., & Delany, A. M. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.6.987 · Cited by 21
Gravellese (2000) · Pure Amsterdam UMC · doi:10.1002/1529-0131(200002)43:2 · Cited by 2
Cited by
Fracture healing under healthy and inflammatory conditions
Claes, L., Recknagel, S., & Ignatius, A. (2012) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2012.1 · Cited by 1,326
Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production
David, V., Martin, A., Isakova, T., Spaulding, C., Qi, L., Ramirez, V., Zumbrennen-Bullough, K. B., Sun, C. C., Lin, H. Y., Babitt, J. L., et al. (2016) · Kidney International · doi:10.1038/ki.2015.290 · Cited by 494
Epidemiology and clinical impact of major comorbidities in patients with COPD
Smith, M., & Wrobel, J. (2014) · International Journal of Chronic Obstructive Pulmonary Disease · doi:10.2147/copd.s49621 · Cited by 407
Glucocorticoids and bone: consequences of endogenous and exogenous excess and replacement therapy
Hardy, R. S., Zhou, H., Seibel, M. J., & Cooper, M. S. (2018) · Endocrine Reviews · doi:10.1210/er.2018-00097 · Cited by 258
Self-citationInfluence of body weight on bone mass, architecture and turnover
Iwaniec, U. T., & Turner, R. T. (2016) · Journal of Endocrinology · doi:10.1530/joe-16-0089 · Cited by 199
Metadata
- Authors
- Hardy, R., & Cooper, M. S.
- Venue
- Journal of Endocrinology
- Publisher
- Bioscientifica
- Published
- 2009-02-24
- Volume
- 201
- Issue
- 3
- Pages
- 309-320
- ISSN
- 0022-0795 (ISSN-L)
- 1479-6805
- OpenAlex
- W2152099215
- Cited by
- 365
- References
- 112
- FWCI
- 6.00
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.